InBioGen Co Ltd Total Liabilities
InBioGen Co Ltd total liabilities. Based on the latest financial reports, InBioGen Co Ltd (101140) has total liabilities worth ₩2.44 Billion KRW (≈ $1.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See InBioGen Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Total Liabilities of InBioGen Co Ltd (2013–2024)
Total liabilities of InBioGen Co Ltd from 2013 to 2024. This chart illustrates how InBioGen Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check InBioGen Co Ltd (101140) asset resilience to evaluate the company's liquid asset resilience ratio.
InBioGen Co Ltd Competitors by Total Liabilities
The table below lists competitors of InBioGen Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Burcelik Bursa Celik Dokum Sanayi AS
IS:BURCE
|
Turkey | TL70.44 Million |
|
Ant Precision Industry Co Ltd
TWO:3646
|
Taiwan | NT$397.76 Million |
|
Tingsvalvet Fastighets AB
ST:TINGS-A
|
Sweden | Skr2.19 Billion |
|
Grid Metals Corp
V:GRDM
|
Canada | CA$977.65K |
|
Kyung Chang Industrial Co. Ltd
KQ:024910
|
Korea | ₩379.37 Billion |
|
Pyung Hwa Hldg
KO:010770
|
Korea | ₩443.86 Billion |
|
Wijaya Karya Beton
JK:WTON
|
Indonesia | Rp2.79 Trillion |
|
New Palace International Co Ltd
TW:8940
|
Taiwan | NT$1.30 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down InBioGen Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see InBioGen Co Ltd assets under control.
Liquidity & Leverage Metrics
InBioGen Co Ltd Total Liabilities Ratios Explained
InBioGen Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how InBioGen Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for InBioGen Co Ltd (2013–2024)
The table below shows the annual total liabilities of InBioGen Co Ltd from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩2.89 Billion ≈ $1.96 Million |
+10.42% |
| 2023-12-31 | ₩2.62 Billion ≈ $1.78 Million |
-92.99% |
| 2022-12-31 | ₩37.40 Billion ≈ $25.35 Million |
-61.22% |
| 2021-12-31 | ₩96.45 Billion ≈ $65.36 Million |
+408.31% |
| 2020-12-31 | ₩18.97 Billion ≈ $12.86 Million |
-23.87% |
| 2019-12-31 | ₩24.92 Billion ≈ $16.89 Million |
+2472.55% |
| 2018-12-31 | ₩968.80 Million ≈ $656.54K |
-53.09% |
| 2017-12-31 | ₩2.07 Billion ≈ $1.40 Million |
-68.82% |
| 2016-12-31 | ₩6.62 Billion ≈ $4.49 Million |
-2.00% |
| 2015-12-31 | ₩6.76 Billion ≈ $4.58 Million |
+126.40% |
| 2014-12-31 | ₩2.99 Billion ≈ $2.02 Million |
-52.87% |
| 2013-12-31 | ₩6.33 Billion ≈ $4.29 Million |
-- |
About InBioGen Co Ltd
INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.